• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Xin,CHENG Gang.Efficacy and safety of active vitamin D in the treatment of type 2 diabetic nephropathy: A meta-analysis[J].Journal Of Pharmaceutical Research,2019,38(11):671-675[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2851times   Download 3636次 QR Code for this article
Scan with your phone!
活性维生素D治疗2型糖尿病肾病有效性与安全性Meta分析
张欣1,2,程刚3
Font:Larger+|Default|Smaller-
(1.沈阳药科大学生命科学与生物制药学院,辽宁 沈阳 110016;2.辽宁省健康产业集团抚矿总医院,辽宁 抚顺 113008;3.沈阳药科大学药学院,辽宁 沈阳 110016)
摘要:
目的 评价活性维生素D治疗2型糖尿病肾病有效性及安全性。方法 计算机检索Cochrane library、Pubmed、Embase数据库。应用RevMan5.2软件进行统计分析。结果 治疗组显著减少24小时尿蛋白[OR=0.28,95%CI(0.24,0.33),P<0.000 01],高血钙不良事件发生率较对照组有显著性差异[OR=4.86,95%CI(1.09,21.56),P=0.04]。结论 活性维生素D治疗2型糖尿病肾病,显著降低患者24小时尿蛋白,但增加高血钙不良事件发生的风险。
关键词:  活性维生素D  糖尿病肾病  Meta分析
DOI:10.13506/j.cnki.jpr.2019.11.013
基金项目:
Efficacy and safety of active vitamin D in the treatment of type 2 diabetic nephropathy: A meta-analysis
ZHANG Xin1,2,CHENG Gang3
(1.College of life sciences and biopharmaceutics,Shenyang pharmaceutical university,Shenyang 110016,China;2.Liaoning health industry group fukuang general hospital,Fushun 113008,China;3.College of pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China)
Abstract:
Objective To evaluate the efficacy of active vitamin D in the treatment of type 2 diabetic nephropathy.Evaluating the safety of active vitamin D in the treatment of type 2 diabetic nephropathy.Methods We retrieved the Cochrane library,Pubmed,Embase databases and other relevant literatures. Meta-analysis was performed using RevMan5.2 software.Results Meta-analysis outcomes showed that vitamin D treatment group significantly reduced 24-hour urine protein [OR=0.28, 95%CI(0.24,0.33),P<0.00001]. There was statistical difference in high calcium blood [OR=4.86, 95%CI (1.09,21.56),P=0.04].Conclusion In this meta-analysis, the use of active vitamin D in the treatment of type 2 diabetic nephropathy can significantly reduce 24-hour urinary protein,but increase the risk of hypercalcemia.
Key words:  Active vitamin D  Diabetic nephropathy  Meta-Analysis
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.